drugset / Trial / NCT06378957
Behavioral Pharmacology of Orally Administered THC and D-limonene
RandomizedCrossoverDouble-blindBasic science
Summary
The current clinical trial will investigate the effects of orally administered d-limonene (limonene), delta-9-tetrahydrocannabinol (THC) and the combination in healthy adult volunteers.
Timeline
- Start
- 2025-02-14
- Primary completion
- 2027-07-01
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dronabinol | Other / unclassified | 30 mg | Oral |
| Subject | d-limonene | Small molecule | 25 mg | Oral |
| Subject | d-limonene | Small molecule | 50 mg | Oral |
| Subject | d-limonene | Small molecule | 100 mg | Oral |
| Subject | d-limonene | Small molecule | 200 mg | Oral |
Indications
No indication recorded.